Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial

Efficacy and safety of exenatide as add‐on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double‐blind trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14225 ◽

2020 ◽

Author(s):

Michael Joubert ◽

Victoria Opigez ◽

Barbora Pavlikova ◽

Laure Peyro Saint Paul ◽

Nathalie Jeandidier ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2017.10.018 ◽

2018 ◽

Vol 138 ◽

pp. 253-261 ◽

Cited By ~ 8

Author(s):

Philip Home ◽

R. Ravi Shankar ◽

Ira Gantz ◽

Carol Iredale ◽

Edward A. O'Neill ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Dipeptidyl Peptidase 4 ◽

Blind Trial ◽

Dipeptidyl Peptidase 4 Inhibitor

Addition of Mitiglinide to Pioglitazone Monotherapy Improves Overall Glycemic Control in Japanese Patients with Type 2 Diabetes: A Randomized Double Blind Trial

Endocrine Journal ◽

10.1507/endocrj.k09e-022 ◽

2009 ◽

Vol 56 (5) ◽

pp. 657-664 ◽

Cited By ~ 8

Author(s):

Kohei KAKU ◽

Shun-ichi TANAKA ◽

Hideki ORIGASA ◽

Masatoshi KIKUCHI ◽

Yasuo AKANUMA

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Japanese Patients ◽

Double Blind Trial ◽

Double Blind ◽

Review for "Efficacy and safety of Exenatide as add‐on therapy for type 2 diabetes patients with intensive insulin regimen: a randomized double‐blind trial"

10.1111/dom.14225/v1/review3 ◽

2020 ◽

Author(s):

Afshin Salsali

Keyword(s):

Type 2 Diabetes ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial ◽

Review for "Efficacy and safety of Exenatide as add‐on therapy for type 2 diabetes patients with intensive insulin regimen: a randomized double‐blind trial"

10.1111/dom.14225/v2/review2 ◽

2020 ◽

Author(s):

Bastiaan de Galan

Keyword(s):

Type 2 Diabetes ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial ◽

Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01494.x ◽

2011 ◽

Vol 14 (2) ◽

pp. 187-189 ◽

Cited By ~ 7

Author(s):

L. Li ◽

M. Yang ◽

Z. Li ◽

X. Yan ◽

H. Guo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Author response for "Efficacy and safety of Exenatide as add‐on therapy for type 2 diabetes patients with intensive insulin regimen: a randomized double‐blind trial"

10.1111/dom.14225/v2/response1 ◽

2020 ◽

Author(s):

Michael Joubert ◽

Victoria Opigez ◽

Barbora Pavlikova ◽

Laure Peyro Saint Paul ◽

Nathalie Jeandidier ◽

...

Keyword(s):

Type 2 Diabetes ◽

Author Response ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial ◽

Decision letter for "Efficacy and safety of Exenatide as add‐on therapy for type 2 diabetes patients with intensive insulin regimen: a randomized double‐blind trial"

10.1111/dom.14225/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial ◽

Decision letter for "Efficacy and safety of Exenatide as add‐on therapy for type 2 diabetes patients with intensive insulin regimen: a randomized double‐blind trial"

10.1111/dom.14225/v1/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial ◽

Review for "Efficacy and safety of Exenatide as add‐on therapy for type 2 diabetes patients with intensive insulin regimen: a randomized double‐blind trial"

10.1111/dom.14225/v2/review3 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial ◽